Silencing of Pellino1 improves post-infarct cardiac dysfunction and attenuates left ventricular remodelling in mice

Cardiovascular Research

Volumn 102, Issue 1, 2014, Pages 46-55

  Wu, Wei ^a   Hu, Yuanping ^a   Li, Jiantao ^a   Zhu, Weina ^a   Ha, Tuanzhu ^b   Que, Linli ^a   Liu, Li ^c   Zhu, Quan ^c   Chen, Qi ^a   Xu, Yong ^a   Li, Chuanfu ^b   Li, Yuehua ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b East Tennessee State University   (United States)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Inflammation; Left ventricular remodelling; Myocardial infarction; Pellino1; TLR IL 1R

Indexed keywords

ADENOVIRUS VECTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PELLINO1 PROTEIN; SCAFFOLD PROTEIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; INTERLEUKIN 1 RECEPTOR; NUCLEAR PROTEIN; PELI1 PROTEIN, MOUSE; TOLL LIKE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GEL MOBILITY SHIFT ASSAY; GENE SILENCING; HEART INFARCTION; HEART LEFT VENTRICLE; HEART VENTRICLE REMODELING; HYPOXIA; IN VITRO STUDY; INFLAMMATORY CELL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION; UBIQUITINATION; ZYMOGRAPHY; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENETICS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; METABOLISM; PHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; GENE SILENCING; MALE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; NUCLEAR PROTEINS; RECEPTORS, INTERLEUKIN-1; TOLL-LIKE RECEPTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84896913626     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu007     Document Type: Article

References (42)

1. Abrahamsson P, Dobson J, Granger CB, Mc Murray JJ, Michelson EL, Pfeffer M et al. Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure. Eur Heart J 2009;30:338-345.
2. Lamas GA, Pfeffer M.A. Increased left ventricular volume following myocardial infarction in man. Am Heart J 1986;111:30-35.
3. Anzai A, Anzai T, Nagai S, Maekawa Y, Naito K, Kaneko H et al. Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling. Circulation 2012;125: 1234-1245.
4. Belvin MP, Anderson KV. A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu Rev Cell Dev Biol 1996;12:393-416.
5. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A et al. In vivo infection of cis element 'decoy' against nuclear factor-kB binding site prevents myocardial infarction. Nat Med 1997;3:894-899.
6. Kawano S, Kubota T, Monden Y, Tsutsumi T, Inoue T, Kawamura N et al. Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction. Am J Physiol Heart Circ Physiol 2006;291:H1337-H1344.
7. Mersmann J, Habeck K, Latsch K, Zimmermann R, Jacoby C, Fischer JW et al. Left ventricular dilation in Toll-like receptor 2 deficient mice after myocardial ischemia/reperfu-sion through defective scar formation. Basic Res Cardiol 2011;106:89-98.
8. Selejan S, Poss J, Walter F, Hohl M, Kaiser R, Kazakov A et al. Ischaemia-induced up-regulation of Toll-like receptor 2 in circulating monocytes in cardiogenic shock. Eur Heart J 2012;33:1085-1094.
9. Oyama J, Blais CJ, Liu X, Pu M, Kobzik L, Kelly RA et al. Reduced myocardial ischemia-reperfusion injury in Toll-like receptor 4-deficient mice. Circulation 2004; 109:784-789.
10. Riad A, Jager S, Sobirey M, Escher F, Yaulema-Riss A, Westermann D et al. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocar-dial infarction in mice. J Immunol 2008;180:6954-6961.
11. Schauvliege R, Janssens S, Beyaert R. Pellino proteins: novel players in TLR and IL-1R signalling. J Cell Mol Med 2007;11:453-461.
12. Moynagh PN. The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling. Trends Immunol 2009;30:33-42.
13. Choi KC, Lee YS, Lim S, Choi HK, Lee CH, Lee EK et al. Smad6 negatively regulates inter-leukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1. Nat Immunol 2006;7:1057-1065.
14. Deng L, Wang C, Spencer E, Yang L, Braun A, You J et al. Activation of the Ik B kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000;103:351-361.
15. Ordureau A, Smith H, Windheim M, Peggie M, Carrick E, Morrice N et al. The IRAK-catalysed activation ofthe E3 ligase functionof Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1. Biochem J 2008;409:43-52.
16. Chang M, Jin W, Sun SC. Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production. Nat Immunol 2009;10:1089-1095.
17. Liu P, Jenkins NA, Copeland NG. A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res 2003;13:476-484.
18. Cao Z, Hu Y, Wu W, Ha T, Kelley J, Deng C et al. The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury. Cardiovasc Res 2009;84:442-451.
19. Pu J, Yuan A, Shan P, Gao E, Wang X, Wang Y et al. Cardiomyocyte- expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial is-chaemia/reperfusion injury. Eur Heart J 2013;34:1834-1845.
20. Zhu Y, Li T, Song J, Liu C, Hu Y, Que L et al. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated My D88-dependent signaling. Basic Res Cardiol 2011;106:787-799.
21. Li J, Wu M, Que L, Wang Y, Xu X, Hu Y et al. 17b-Estradiol attenuatescardiac dysfunction and decreases NF-kB binding activity in mechanically stretched rat hearts. Steroids 2008; 73:720-726.
22. Cho A, Reidy M.A. Matrix m et al loproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res 2002;91:845-851.
23. Goh ET, Arthur JS, Cheung PC, Akira S, Toth R, Cohen P. Identification of the protein kinases that activate the E3 ubiquitin ligase Pellino1 in the innate immune system. Biochem J 2012;441:339-346.
24. Li C, Ha T, Kelley J, Gao X, Qiu Y, Kao RL et al. Modulating Toll-like receptor mediated signaling by (1-. 3)-b-D-glucan rapidly induces cardioprotection. Cardiovasc Res 2004; 61:538-547.
25. Mori S, Gibson G, Mc Tiernan CF. Differential expression of MMPs and TIMPs in moderate and severe heart failure in a transgenic model. J Card Fail 2006;12:314-325.
26. Muroi M, Tanamoto K. IRAK-1-mediated negative regulationofToll-like receptor signaling through proteasome-dependent downregulation of TRAF6. Biochim Biophys Acta 2012;1823:255-263.
27. Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, Ho A et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 1999;13:1015-1024.
28. Grosshans J, Schnorrer F, Nusslein-Volhard C. Oligomerisation of Tube and Pelle leads to nuclear localisation of dorsal. Mech Dev 1999;81:127-138.
29. Jiang Z, Johnson HJ, Nie H, Qin J, Bird TA, Li X. Pellino1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex. J Biol Chem 2003;278:10952-10956.
30. Volz HC, Laohachewin D, Seidel C, Lasitschka F, Keilbach K, Wienbrandt AR et al. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-kB signaling. Basic Res Cardiol 2012;107:250.
31. Schauvliege R, Janssens S, Beyaert R. Pellino proteins are more than scaffold proteins in TLR/IL-1R signalling: a role as novel RING E3-ubiquitin-ligases. FEBS Lett 2006;580: 4697-4702.
32. Skaug B, Jiang X, Chen ZJ. The role of ubiquitin in NF-kB regulatory pathways. Annu Rev Biochem 2009;78:769-796.
33. Ock S, Ahn J, Lee SH, Park H, Son JW, Oh JG et al. Receptor activatorofnuclear factor-kB ligand is a novel inducer of myocardial inflammation. Cardiovasc Res 2012;94:105-114.
34. Xia ZP, Sun L, Chen X, Pineda G, Jiang X, Adhikari A et al. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 2009;461:114-119.
35. Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, Zhang YE. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-b. Mol Cell 2008;31:918-924.
36. Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ. Activation of IKK by TNFa requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 2006;22: 245-257.
37. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. TRAF6 is a signal transducer for interleukin-1. Nature 1996;383:443-446.
38. Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T, Takeda K et al. Toll/IL-1 receptor domain-containing adaptor inducing IFN-b (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-k B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J Immunol 2003;171:4304-4310.
39. Morimoto H, Takahashi M, Izawa A, Ise H, Hongo M, Kolattukudy PE et al. Cardiac over-expression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Circ Res 2006;99:891-899.
40. Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH et al. Matrix m et al loproteinases/tissue inhibitors of m et al loproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 2006; 113:2089-2096.
41. Romanic AM, Harrison SM, Bao W, Burns-Kurtis CL, Pickering S, Gu J et al. Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix m et al loproteinase-9. Cardiovasc Res 2002;54:549-558.
42. Li YF, Xu XB, Chen XH, Wei G, He B, Wang JD. The nuclear factor-kB pathway is involved in matrix m et al loproteinase-9 expression in RU486-induced endometrium breakdown in mice. Hum Reprod 2012;27:2096-2106.